VYNE Therapeutics Inc. Gains 70.05%
Wed, Jan 04, 2023 at 07:00 PM
VYNE Therapeutics Inc. (VYNE:NASDAQ) shot up at $0.24, representing a gain of 70.1%. On Wed, Jan 04, 2023, VYNE:NASDAQ touched a New 2-Week High of $0.24. The stock appeared on our News Catalysts scanner on Mon, Dec 12, 2022 at 09:11 AM in the 'MISCELLANEOUS' category. From Wed, Dec 21, 2022, the stock recorded 50.00% Up Days and 44.44% Green Days
The stock spiked on Wed, Jan 04, 2023 at $0.37 with a volume of 13M+.
About VYNE Therapeutics Inc. (VYNE:NASDAQ)
VYNE Therapeutics Inc is a biopharmaceutical company which focuses on the development and commercialization of variety of solutions using its proprietary Molecule Stabilizing Technology.
Top 10 Gainers:
- Vivos Therapeutics Inc. (VVOS:NASDAQ), 154.05%
- Cryptyde Inc. (TYDE:NASDAQ), 81.35%
- VYNE Therapeutics Inc. (VYNE:NASDAQ), 70.05%
- Shift Technologies Inc. (SFT:NASDAQ), 57.5%
- Relativity Acquisition Corp. (RACY:NASDAQ), 47.65%
- eFFECTOR Therapeutics Inc. (EFTR:NASDAQ), 44.9%
- Elys Game Technology Corp. (ELYS:NASDAQ), 39.96%
- Reunion Neuroscience Inc. (REUN:NASDAQ), 39.42%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 37.72%
- Theseus Pharmaceuticals Inc. (THRX:NASDAQ), 36.28%